Traders Circulate Comment From JP Morgan On PTC Therapeutics: 'Solid Updates for Risdi at WMS. Near-term Buying Opp'y on Unfounded Weakness'; PTC Shares Down 3% For Session, But Up ~16% From Session Low Just After Open
Benzinga Newsdesk